News

SEC Filings

Document Details

Form
Filing Date
June 9, 2020
Document Date
June 5, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Ho Carole

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com